TRPC3 and cardiac hypertrophy: Inhibition of TRPC3 has been explored as a possible intervention for cardiac hypertrophy in a mouse model, where some improvement was seen, but effects were limited by lack of TRPC3 inhibitor compounds with a desirable ADME (absorption, distribution, metabolism and excretion) profile [61].